Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Advances and Perspectives in the Treatment of T-PLL.
Curr Hematol Malig Rep. 2020 Apr;15(2):113-124. doi: 10.1007/s11899-020-00566-5.
Curr Hematol Malig Rep. 2020.
PMID: 32034661
Free PMC article.
PURPOSE OF REVIEW: T cell prolymphocytic leukemia (T-PLL) is a rare mature T cell tumor. Available treatment options in this aggressive disease are largely inefficient and patient outcomes are highly dissatisfactory. ...
PURPOSE OF REVIEW: T cell prolymphocytic leukemia (T-PLL) is a rare mature T cell tumor. Available treatment options in this a …
PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.
Nachat A, Turoff-Ortmeyer S, Liu C, Mcculloch M.
Nachat A, et al.
Perm J. 2016 Spring;20(2):74-80. doi: 10.7812/TPP/15-153.
Perm J. 2016.
PMID: 27168399
Free PMC article.
Review.
INTRODUCTION: B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive leukemia distinct from chronic lymphocytic leukemia, with median survival of only 3 years. ...
INTRODUCTION: B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive leukemia distinct from chronic lymphocytic leukemia …
Item in Clipboard
Cite
Cite